The Central government has dispelled the rumour doing the rounds on social media that the COVAXIN vaccine contains the newborn...
Bharat Biotech
In a setback to Bharat Biotech, the United States top public health regulator, Federal Drug Administration (FDA), has not given...
The Drugs Controller General of India (DCGI) has approved Phase 2 and 3 clinical trials of Bharat Biotech's Covid vaccine...
Bharat Biotech has announced the cost of Covid-19 vaccine Covaxin for third phase of vaccination that will kickstart next month....
Serum Institute of India (SII) has fixed a price of Rs 600 per dose for Covid-19 vaccine Covishield supplies to...
It is a long story, indeed. And it started long before 3 January 2021, when Drug Controller General of India...
The long wait for India's 1.3 billion people is over as the country's drug regulator has given emergency approval to...
As India gears up for its Covid-19 inoculation drive against the pandemic, Serum Institute of India’s Covishield and Bharat Biotech...